CME Group stock: UBS raises target for CME Group stock to USD 310.00

Published on 10/22/2026 at 16:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 revenue hit USD 1.74 billion, up 13.00 percent. CME Group stock costs EUR 271.68 on October 22, 2026, up 2.60 percent versus Tradegate close.

Analyst target and results

UBS lifted its CME Group target from USD 270.00 to USD 310.00 on October 22, 2026.
Third-quarter revenue reached USD 1.74 billion, up 13.00 percent year over year.
CME Group stock costs EUR 271.68 at Lang & Schwarz on October 22, 2026 at 4:03 p.m. CEST, up 2.60 percent versus the Tradegate close of October 21, 2026.
CME Group reported 29.40 million average daily contracts in the third quarter of 2026.

Schwarz-Weiß Reportagefoto von Händlern auf einem lebhaften Börsenparkettboden — CME Group Inc. Börsenhändler in dramatischem Schwarzweiß-Reportagestil dokumentiert, ISIN US12572Q1058 hautnah festgehalten, Illustration mit AI erstellt.

UBS raised its CME Group price target from USD 270.00 to USD 310.00 on October 22, 2026, while maintaining a Neutral rating, according to Investing.com. CME Group stock was trading at EUR 271.68 at Lang & Schwarz on October 22, 2026 at 4:03 p.m. CEST, up 2.60 percent versus the Tradegate close of October 21, 2026 at EUR 264.80.

UBS target reaches USD 310.00

The revised target stands 1.36 percent above the USD 305.83 Nasdaq price used for the comparison. UBS kept its Neutral rating and cited new initiatives including single-stock futures, compute contracts and Treasury Link, while pointing to regulatory uncertainty as a risk, Investing.com.

Third-quarter revenue reaches USD 1.74 billion

CME Group reported third-quarter 2026 revenue of USD 1.74 billion, compared with USD 1.54 billion in the third quarter of 2025. Net income rose to USD 1.04 billion from USD 908.00 million, while diluted GAAP earnings per share increased to USD 2.89 from USD 2.49, according to CME Group.

Adjusted diluted earnings per share reached USD 3.02 in the third quarter, above the USD 2.99 FactSet consensus cited by Morningstar. Market data revenue rose 20.00 percent to USD 243.10 million, giving the business a second quantified growth marker.

29.40 million contracts set the operating frame

Average daily volume reached 29.40 million contracts in the third quarter of 2026, up from 25.30 million a year earlier. Non-US volume reached 9.00 million contracts, while clearing and transaction fees totaled USD 1.38 billion for the quarter, CME Group.

Valuation and upcoming date

CME Group had a USD 110.0 billion market capitalization and a 25.05 price-to-earnings ratio. The company is scheduled to launch CME Securities Clearing on December 7, 2026, according to Benzinga.

Comparison with peers

CME Group Inc.: up 2.60 percent, price-to-earnings ratio 25.05, market capitalization USD 110.0 billion.

Intercontinental Exchange (NYSE, USD): up 2.46 percent, price-to-earnings ratio 22.75, market capitalization USD 90.7 billion.

Nasdaq (Nasdaq, USD): up 6.10 percent, price-to-earnings ratio 37.84, market capitalization USD 57.0 billion.

Trading position after the results

The latest move places CME Group stock above the previous Tradegate close, while the operating figures show how higher contract activity supported the third-quarter revenue increase. The next dated corporate milestone is the December 7, 2026 clearing launch.

The stock was trading at EUR 271.68 at Lang & Schwarz on October 22, 2026 at 4:03 p.m. CEST, up 2.60 percent versus the Tradegate close of October 21, 2026 at EUR 264.80. The further course of trading is shown by the continuously updated real-time quote of CME Group stock.